StonvexLoading…
StonvexStonvexStonvexCore line items from APYX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $12.49M | $52.84M | $33.68M | $20.80M |
Operating Income | $-911.00K | $-6.45M | $-6.46M | $-5.63M |
Net Income | $-2.11M | $-11.21M | $-9.91M | $-7.93M |
EPS (Diluted) | $-0.05 | $-0.27 | $-0.24 | $-0.19 |
Total Assets | $63.02M | $66.84M | $57.37M | $58.19M |
Total Liabilities | $49.94M | $52.01M | $51.28M | $50.73M |
Cash & Equivalents | $31.14M | $31.74M | $25.14M | $29.30M |
Free Cash Flow OCF − CapEx | $-632.00K | $-9.12M | $-6.31M | $-2.25M |
Shares Outstanding | 41.87M | 41.79M | 37.82M | 37.79M |